CCND1 silencing suppresses liver cancer stem cell differentiation and overcomes 5-Fluorouracil resistance in hepatocellular carcinoma
Objective: Chemoresistance is one of the major barriers in chemotherapy-based hepatocellular carcinoma (HCC) intervention. 5-Fluorouracil (5-Fu) is a widely used as an anticancer drug. Liver cancer stem cells (LCSCs) are considered the origin of tumor recurrence and resistance. CCND1 (Cyclin D1) pla...
Main Authors: | Hao Ding, Yijun Wang, Hongying Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-07-01
|
Series: | Journal of Pharmacological Sciences |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1347861320300426 |
Similar Items
-
Melatonin Sensitizes Hepatocellular Carcinoma Cells to Chemotherapy Through Long Non-Coding RNA RAD51-AS1-Mediated Suppression of DNA Repair
by: Chin-Chuan Chen, et al.
Published: (2018-09-01) -
LncRNA HOTAIR Regulates CCND1 and CCND2 Expression by Sponging miR-206 in Ovarian Cancer
by: Lei Chang, et al.
Published: (2018-09-01) -
Association between polymorphisms in MicroRNA target sites of RAD51D genes and risk of hepatocellular carcinoma
by: Yan‐Ji Jiang, et al.
Published: (2019-05-01) -
Allicin sensitizes hepatocellular cancer cells to anti-tumor activity of 5-fluorouracil through ROS-mediated mitochondrial pathway
by: Xuejing Zou, et al.
Published: (2016-08-01) -
Inhibition of EGR1 inhibits glioma proliferation by targeting CCND1 promoter
by: Dian-gang Chen, et al.
Published: (2017-12-01)